News for Healthier Living

AACR: Clinical Trial Presentations Feature Advances Across Cancer Care

Early results for first-in-human and first-in-class therapies including an integrin inhibitor and a genetically engineered tumor infiltrating lymphocyte therapy ctDNA monitoring may be changing treatment options for patients Next-generation targeted therapies may allow de-escalation of treatment Researchers from The University of Texas MD Anderson Cancer Center will present initial data from six clinical trials during minisymposia at this week's American Association for Cancer Research (AACR) Annual Meeting 2026.

April 17, 2026


April 17 2026

April 16 2026

April 15 2026

April 14 2026

April 13 2026

April 12 2026

April 11 2026

April 10 2026

April 9 2026

April 8 2026

April 7 2026

April 6 2026

April 5 2026

April 4 2026